Singular news
Singular appears in 2 stories we have published between October 2026 and November 2026, mostly in our AI coverage. It is most often reported alongside Adjust, Airbridge and AppsFlyer.
Latest development
Orakl Oncology raises $34M to predict cancer drug success with AI
Orakl Oncology has raised $34 million to predict which cancer drugs will work before they enter clinical trials. The Series A round, led by Norrsken VC and Singular, brings the Paris-based startup’s total funding to $50 million since its 2023 spinout from Gustave Roussy. Orakl uses AI and lab-grown tumor models to forecast drug efficacy, aiming to save pharma years and millions in trial costs.
13 November 2026
Orakl Oncology raises $34M to predict cancer drug success with AI
Orakl Oncology raises $34M to predict cancer drug efficacy using AI and lab-grown tumor organoids. 18 of the world’s top 20 drugmakers are in talks.
OpenAI tests visual ads and Intelligent UI in ChatGPT
OpenAI is launching visual ads and a new interactive interface for ChatGPT. Learn how these changes could impact users, advertisers, and AI product development.